LncRNAs-circRNAs as Rising Epigenetic Binary Superstars in Regulating Lipid Metabolic Reprogramming of Cancers

As one of novel hallmarks of cancer, lipid metabolic reprogramming has recently been becoming fascinating and widely studied. Lipid metabolic reprogramming in cancer is shown to support carcinogenesis, progression, distal metastasis, and chemotherapy resistance by generating ATP, biosynthesizing macromolecules, and maintaining appropriate redox status. Notably, increasing evidence confirms that lipid metabolic reprogramming is under the control of dysregulated non-coding RNAs in cancer, especially lncRNAs and circRNAs. This review highlights the present research findings on the aberrantly expressed lncRNAs and circRNAs involved in the lipid metabolic reprogramming of cancer. Emphasis is placed on their regulatory targets in lipid metabolic reprogramming and associated mechanisms, including the clinical relevance in cancer through lipid metabolism modulation. Such insights will be pivotal in identifying new theranostic targets and treatment strategies for cancer patients afflicted with lipid metabolic reprogramming. The lipid metabolism-related lncRNAs and circRNAs have emerged as rising epigenetic binary superstars in regulating lipid metabolic reprogramming of cancers. In this review, their regulatory targets, associated mechanisms, as well as clinical relevance are summarized to cast light on identifying new theranostic targets and treatment strategies for cancer patients afflicted with lipid metabolic reprogramming.image

Automated summary

Lipid metabolic reprogramming plays a crucial role in cancer, and dysregulated non-coding RNAs, especially lncRNAs and circRNAs, are involved in the regulation of this process. Understanding their regulatory targets and mechanisms is important for identifying new therapeutic targets and treatment strategies for cancer patients with lipid metabolic reprogramming.